4/A//SEC Filing
Quirk Gerald E 4/A
Accession 0001209191-20-064671
CIK 0001556263other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:01 PM ET
Size
5.8 KB
Accession
0001209191-20-064671
Insider Transaction Report
Form 4/AAmended
Quirk Gerald E
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2016-09-27+35,000→ 35,000 totalExercise: $13.30Exp: 2026-09-26→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]This option was inadvertently omitted from Mr. Quirk's original Form 4 filed on September 29, 2016.
- [F2]This option vests upon the earlier of (i) the achievement of specified performance-based criteria, as determined by the Issuer's Board of Directors, and (ii) September 26, 2022, subject to Mr. Quirk's continued service as an employee through the vesting date.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001479603
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 5:01 PM ET
- Size
- 5.8 KB